Table 1.
Clinical Experience With Intermittent Androgen Blockade
| Investigator | Mean Follow-Up | |
|---|---|---|
| (year) | Clinical Stage | (mo) |
| Goldenberg (1995)24 | Local + metastatic | 30 |
| Gleave (1997)25 | Local + metastatic | 46 |
| Higano (1996)26 | Local + metastatic | 26 |
| Oliver (1997)27 | Local + metastatic | NA |
| Grossfeld (1998)28 | Local | 24 |
| Bruchovsky (1997)29 | Local | NA |
| Horwich (1998)31 | Metastatic | NA |
| Kurek (1999)32 | Local | 48 |
| Tunn (1996)33 | Local | 48 |
| Crook (1999)38 | Local + metastatic | 33 |
NA, not applicable.